Chronic myeloid leukemia: Symptoms, outlook, and more
Medical News Today· 2 days agoThe symptoms and treatment options can vary according to the stage of CML. Doctors may sometimes...
Aprea Therapeutics to Host Virtual R&D Day on April 22, 2021
Morningstar· 1 day agoAprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate the mutant tumor suppressor protein, ...
Ascentage Pharma Releases Preclinical Data of Its Core Drug Candidates at AACR Annual Meeting 2021,...
Morningstar· 5 days agoSUZHOU, China and ROCKVILLE, Md., April 12, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for ...
Stephen B. Meltzer, commercial photographer, dies
Baltimore Sun via Yahoo News· 5 days agoStephen B. Meltzer, a former Baltimore commercial photographer, died March 26 from acute myeloid leukemia at a son’s home in Pikesville ...
Molecular Partners Shares New Preclinical Data from its AML-Focused CD3 T-Cell Engager Program, CD40...
Digital Journal· 7 days agoThe preclinical data shared include results from the Company's acute myeloid leukemia (AML) CD3 T-cell engager program, new data from ...
Comprehensive germline-genomic and clinical profiling in 160 unselected children and adolescents...
Nature· 5 days agoA detailed clinical description of the complete cohort of patients is summarized in Supplementary Table 1. Leukemia, including 48 acute lymphoblastic leukemia (ALL) and 11 acute< ...
Gilead’s Bladder Cancer Drug Trodelvy Gets FDA Nod
SmarterAnalyst· 3 days agoGilead Sciences’ Trodelvy (sacituzumab govitecan-hziy) has been granted accelerated approval by the US Food and Drug Administration (FDA) for use in the
Gilead’s Bladder Cancer Drug Trodelvy Gets FDA Nod
SmarterAnalyst via Yahoo Finance· 3 days agoGilead Sciences’ Trodelvy (sacituzumab govitecan-hziy) has been granted accelerated approval by the US Food and Drug Administration (FDA) for use in the...
St. Louis biotech startup Wugen names Daniel Kemp as its CEO - St. Louis Business Journal
The Business Journals· 3 days agoThe CEO joins the fast-growing startup as it has scaled operations in recent months.
Raymond James Predicts Over 60% Rally for These 2 Stocks
TipRanks via Yahoo Finance· 4 days agoGoing ahead, Raymond James strategist Tavis McCourt believes we’re looking at a prolonged period of...